Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03371381
Title An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab Versus Nivolumab Monotherapy in Participants With Advanced Adenocarcinoma of the Lung
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Janssen Research & Development, LLC
Indications

lung adenocarcinoma

Therapies

JNJ-64041757 + Nivolumab

Nivolumab

Age Groups: adult | senior
Covered Countries USA | ESP | BEL

Additional content available in CKB BOOST